跳至主要内容
临床试验/NCT06757452
NCT06757452已完成3 期

The Effect of Supplementation with Curcuminoids for the Improvement of Musculoskeletal Conditions in Sedentary Adults

Lissette Ariza Corredor2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年7月5日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
RMSSD

研究概览

简要总结

The aim of this study is to evaluate the effect of a supplementation with curcuminoids, called Cal LX, prior to physical exercise, on the improvement of musculoskeletal conditions in sedentary people, which would lead to more physical exercise regularly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be over 25 years old
  • To have not exercised systematically during the last 3 months, or do not do physical exercise daily for more than 25 minutes per day for a maximum of 3 days per week
  • Sitting for at least 4 hours continuously
  • Type 2 diabetes patients.

排除标准

  • To have a history or diagnoses of cardiopulmonary, osteoarticular, type 1 diabetes or autoimmune disorders
  • Pregnancy

结局指标

主要结局

RMSSD

时间窗: Twice a week, prior and after the physical activity, during the three monts of intervention

An indicator of parasympathetic activity by evaluating the root mean square of successive differences between normal heartbeats (RMSSD) determined in milliseconds, which is directly associated with short-term heart rate variability.

次要结局

  • Creatinine(Every 30 days, begining the first day physical activity, during the three monts of intervention.)
  • CK(Every 30 days, begining the first day physical activity, during the three monts of intervention.)
  • LDH(Every 30 days, begining the first day physical activity, during the three monts of intervention.)
  • Urea(Every 30 days, begining the first day physical activity, during the three monts of intervention.)
  • SOD(Every 30 days, begining the first day physical activity, during the three monts of intervention.)

研究者

发起方
Lissette Ariza Corredor
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Lissette Ariza Corredor

R&D Manager

Inbiotech

研究点 (2)

Loading locations...

相似试验